StockData
GRAIL, Inc. logo

GRAIL, Inc. (GRAL) stock

GRALNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 10/30
$115.89−5.46 (-4.50%)

Close on Nov 13, 2026Market cap $5.18BP/E –Yield –

Grail enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Grail's enterprise value was $4.75B on Nov 11, 2026, against $3.45B a year earlier. Over the last 2 years it ranged from -$272.49M to $5.55B, with a median of $1.30B.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$4.75B+85.9%
2025Dec 31, 2025$2.56B–
2024Dec 31, 2024-$260.86M–

More Grail figures

See a number that looks wrong?